Document is current
Any future updates will be listed below
-
Authors
Ljunggren, Malin
Weibull, Caroline E.
Rosander, Emma
Palmer, Gabriella
Glimelius, Bengt
Martling, Anna
Nordenvall, Caroline
-
Funding
Funding for this research was provided by:
Cancerfonden
The Stockholm Cancer Society
The regional agreement on medical training and clinical research between the Stockholm County Council and Karolinska Institutet
Karolinska Institute
- License Information
-
More Information
Article History
Received: 6 May 2022
Accepted: 16 August 2022
First Online: 19 August 2022
Declarations
:
: The study was approved by the Regional Board of the Ethical Committee in Stockholm, Sweden (DNR: 2014/71–31, 2018/328–32, 2021–00342) and the study was conducted in accordance with the Declaration of Helsinki and the ethical standards described in the ethical permit. The requirement for informed consent was waived by the same ethics committee as mentioned above.
: Not applicable. No individual person’s data in the manuscript.
: Dr. Weibull is part of a research collaboration between Karolinska Institutet and Janssen Pharmaceutica NV for which Karolinska Institutet has received grant support. This was unrelated to this study. The other authors declare no competing interests.
